Cardiol Therapeutics Price To Sales Ratio Over Time
| CRDL Stock | CAD 1.61 0.08 4.73% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cardiol Therapeutics Performance and Cardiol Therapeutics Correlation. Cardiol |
Cross Equities Price To Sales Ratio Analysis
Compare Cardiol Therapeutics and related stocks such as Medipharm Labs Corp, Avicanna, and Medicenna Therapeutics Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LABS | 21.7231 | 21.7231 | 21.7231 | 21.7231 | 21.7231 | 21.7231 | 21.7231 | 21.7231 | 21.7231 | 3.5837 | 2.0391 | 2.1295 | 0.8763 | 0.7143 | 0.82 | 0.78 |
| AVCN | 3.2 K | 3.2 K | 3.2 K | 3.2 K | 3.2 K | 3.2 K | 3.2 K | 3.2 K | 826 | 303 | 24.5267 | 9.8511 | 5.9929 | 1.7656 | 2.03 | 1.93 |
| MDNA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| CWEB | 80.4096 | 80.4096 | 80.4096 | 80.4096 | 80.4096 | 80.4096 | 80.4096 | 29.9948 | 15.1853 | 7.8379 | 4.3327 | 1.4942 | 1.0252 | 0.4843 | 0.56 | 0.53 |
| PCLO | 372 | 372 | 372 | 372 | 372 | 372 | 372 | 372 | 372 | 372 | 88.2025 | 73.3808 | 4.9771 | 18.6895 | 4.029 | 3.83 |
Cardiol Therapeutics and related stocks such as Medipharm Labs Corp, Avicanna, and Medicenna Therapeutics Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Cardiol Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cardiol Therapeutics sales, a figure that is much harder to manipulate than other Cardiol Therapeutics Class multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Cardiol Therapeutics Class | CRDL |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 2265 Upper Middle |
| Exchange | Toronto Exchange |
CAD 1.61
Check out Cardiol Therapeutics Performance and Cardiol Therapeutics Correlation. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Cardiol Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.